| Literature DB >> 27318686 |
Dirk De Ruysscher1,2, Karin Haustermans3, Daniela Thorwarth4.
Abstract
Although many PET tracers are in use, FDG still is the most widely used in clinical oncology practice. FDG therefore deserves an in-depth discussion, which is even more interesting because of the huge increase in the molecular biology of glucose metabolism. Obviously, other tracers are of increasing importance as well, and these will be discussed in short.Entities:
Keywords: FDG; Hypoxia; Molecular imaging; PET; Target volume; Tracer
Mesh：
Substances：
Year: 2016 PMID： 27318686 DOI： 10.1007/978-3-662-49651-0_8
Source DB: PubMed Journal: Recent Results Cancer Res ISSN： 0080-0015